Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Breast cancer survivors aged 60+ and with overweight/obesity who had completed chemotherapy 1-6 years earlier completed 8 weeks of 12-8 pm weekday-only time-restricted eating. The intervention was delivered by a registered dietitian call, twice-daily automated text messages asking about eating start/stop times, and three support phone calls.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Weekday time-restricted eating | Experimental | The intervention consisted of 8 weeks of ad libitum TRE with a 12-8 pm 8-hour eating window on weekdays. Participants received instructions to only consume water, black coffee, or black tea from 8 pm to 12 pm on weekdays and during the weekend, where there were no restrictions on eating timing. No other dietary or physical activity instructions were given. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Time-restricted eating | Behavioral | Restriction of calorie intake to an 8-hour window, with water only fasting in the remaining 16 hours of the 24-hour period |
|
| Measure | Description | Time Frame |
|---|---|---|
| Framingham 10-year cardiovascular risk score (%) | Calculated using the Canadian Cardiovascular scoring system | 8 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Visceral adipose tissue | measured via magnetic resonance fat-water separation imaging | 8 weeks |
| Thigh adipose tissue fraction | Relative measure of amount of inter+intra muscular adipose tissue within the thigh muscle measured via magnetic resonance fat-water separation imaging |
| Measure | Description | Time Frame |
|---|---|---|
| Dietary intake | Measured via diet records on 3 consecutive weekdays that were analyzed via Food Processor Nutrition Analysis Software | 8 weeks |
| Activity | 24-hour Measured via Sensewear Pro accelerometer worn on the arm for 3 consecutive weekdays |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Edmonton Clinic Health Academy | Edmonton | Alberta | Canada |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001943 | Breast Neoplasms |
| ID | Term |
|---|---|
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D001941 | Breast Diseases |
| D012871 | Skin Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| 8 weeks |
| Liver adipose tissue fraction | Relative measure of amount of adipose tissue within the liver | 8 weeks |
| Cardiorespiratory fitness | Measured as peak volume of oxygen consumed collected with a cycle erogmeter exercise test | 8 weeks |
| Resting energy expenditure | Collected via metabolic cart in supine resting position after overnight fast | 8 weeks |
| Respiratory quotient | Collected via metabolic cart in supine resting position after overnight fast | 8 weeks |
| Lipid profile | Collected via analysis of fasting blood sample by Lifelabs commercial laboratory | 8 weeks |
| Hemoglobin A1c | Collected via analysis of blood sample by Lifelabs commercial laboratory | 8 weeks |
| Waist circumference | measured as the average of two measurements to the nearest 0.5 cm. | 8 weeks |
| Fasting glucose | Collected via analysis of fasting blood sample by Lifelabs commercial laboratory | 8 weeks |
| Fasting insulin | Collected via analysis of fasting blood sample by Lifelabs commercial laboratory | 8 weeks |
| Resting systolic and diastolic blood pressure | measured as the average of two measurements 60 seconds apart following 5-10 minutes of supine rest using an automated device | 8 weeks |
| Body mass | measured by physicians scale after overnight fast | 8 weeks |
| Whole-body fat mass | estimated using8-point bioelectric impedance (Seca) | 8 weeks |
| Whole-body fat-free mass | estimated using8-point bioelectric impedance (Seca) | 8 weeks |
| Change between measurement at baseline and 8 weeks |
| Adherence to intervention | Collected via participant responses to automated text messages asking participants to self-report the time they started and stopped eating each day. Calculated as the % of prescribed days to follow the intervention where participant reported performing a 16 hour or longer fast. | Ongoing for duration of intervention |
| Participant acceptability | assessed by a researcher-developed end of study questionnaire as: 1) a subjective difficulty rating for following TRE on a scale of 1-10 and 2) rating the dietitian and support calls as 'very helpful' or 'somewhat helpful' on a 5-point Likert scale (other options were 'neutral,' 'somewhat helpful,' and 'unhelpful') | 8 weeks |
| Intervention fidelity | determined as completion rates of the intervention components (registered dietitian consult call, the three support calls, and response rate to the text messages) | 8 weeks |
| Intervention sustainability | Rate of continuing to follow TRE one-month post-intervention completion (without further support or instructions) collected by phone follow-up | 1 month post intervention |
| Intervention sustainability confidence | Average subjective rating of confidence, on 0-100% scale, in ability to follow TRE for one year or longer | 8 weeks |
| Intervention delivery cost | Estimated as average time spent by personnel on intervention delivery multiplied by the hourly rate for that personnel | Through study completion, lasting 12-24 weeks depending on chemotherapy protocol |
| Symptoms | Collected at each of the support phone calls at weeks 1, 3, 6 of the intervention. The research coordinator asked participants if they experienced any symptoms on a pre-determined list or any additional symptoms. Symptoms were only recorded if the participant reported that they were related to the intervention or were unsure if they were related. Symptoms attributed to other life events (i.e., heat wave, stress at work) were not recorded. | Through study completion, lasting 12-24 weeks depending on chemotherapy protocol |
| D017437 |
| Skin and Connective Tissue Diseases |